John W. Severinghaus Lecture - Translational Science: Genomics & Medicine: Present and Future
Printer-friendly version
PDF version
Tuesday, October 16 • 11:30 a.m. – 12:20 p.m.
Walter E. Washington Convention Center
Grand Ballroom A-C
Debra A. Schwinn, M.D., is Professor & Chair of the Department of Anesthesiology & Pain Medicine, and Adjunct Professor of Pharmacology and Genome Sciences, at the University of Washington in Seattle. Dr. Schwinn is a member of the Institute of Medicine and Association of American Physicians, Chair of the Board of Trustees of the International Anesthesia Research Society and immediate past Chair of the Board of Trustees of the Sarnoff Cardiovascular Research Foundation.
Some of Dr. Schwinn's molecular pharmacology research focuses on mechanisms underlying α1-adrenergic receptor regulation and modulation in cardiovascular disease, including the biological effects of genetic variants of these stress receptors. In parallel, over the last decade, her clinical studies have focused on perioperative genomics, a relatively new field aimed at identifying genetic variants that predict increased risk for perioperative adverse events. Prior to moving to the University of Washington in 2007, Dr. Schwinn was appointed Program Director for Cardiovascular Genomics at Duke's Institute for Genome Sciences & Policy, and she completed a sabbatical at the National Human Genome Research Institute at the NIH. One of Dr. Schwinn's aims in moving to Seattle as Chair of Anesthesiology & Pain Medicine was to establish a world-class interdisciplinary pain center designed to move pain medicine to the next level. It is Dr. Schwinn's philosophy that ultimate success of those in leadership today will be measured by how we equip our current trainees to use anesthesiology as an effective and creative acute care medicine platform to change medicine for the better.